http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103721245-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2014-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103721245-B |
| titleOfInvention | Thymopeptide application in the reagent preparing reversing tumor associated gene mutation |
| abstract | The invention discloses Thymopeptide application in the reagent preparing reversing tumor associated gene mutation, widen the range of application of Thymopeptide, tumor patient can make tumour associated gene mutation reverse after intervening Thymopeptide, reduce the Sudden Changing Rate of tumor-related gene, hypertrophy or polyp reduce, extend the life cycle of tumor patient, for the thinking that the targeted therapy offer of tumor is new, there is important clinical meaning. |
| priorityDate | 2014-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 384.